Pfizer has terminated a Phase I trial of its investigational STING therapy in advanced solid tumors, according to an update ...

Great Lakes Hemophilia Foundation created Milwaukee’s Best Bloody to raise funds and awareness for bleeding disorders in Southeastern Wisconsin.

A greater range of motion before knee replacement surgery is associated with better post-surgical outcomes among people with ...

Columnist Alliah Czarielle urges those with hemophilia to remember the power of movement, even if they sense that activity invites trouble.

One Indianapolis family is packing their bags for Washington, D.C. to advocate for better healthcare policies for those with ...

“Gene therapy for hemophilia A with the use of lentiviral vector-transduced autologous HSCs resulted in stable factor VIII ...

A hematologist oncologist is a doctor who specializes in treating cancers of the blood. They have extra training in the blood system, lymphatic system, bone marrow, and cancers. The term “hemato ...

When a test determined that Walter had hemophilia, his Omaha owner joined a group seeking to raise $50,000 for a clinical trial of a gene therapy for dogs. Emily Wiley wasn’t looking to take ...

NEW YORK – Pfizer has discontinued its gene therapy for hemophilia B, Beqvez (fidanacogene elaparvovec), for which the company received regulatory approvals in the US and elsewhere last year. Pfizer ...

Pfiz­er is end­ing the de­vel­op­ment and com­mer­cial­iza­tion of its he­mo­phil­ia B gene ther­a­py Be­qvez, the com­pa­ny con­firmed in an emailed state­ment to End­points ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...